Trials / Completed
CompletedNCT03951792
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 220 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.
Detailed description
The purpose of this research is to learn about how the gastrointestinal bacteria (microbiome) can contribute to colon cancer, and how it may change due to colon cancer. In addition, we are going to study the features of the microbiome that can help predict recovery after colon resection. To do this, we are going to compare the microbiome from subjects with colon cancer to subjects without colon cancer. Study participation involves collection of stool samples before and after your surgery, as well as samples of residual (left-over) colon tissue from your surgery. We would also like to collect optional samples from your follow-up colonoscopy. You may be in the study for up to 5 years.
Conditions
Timeline
- Start date
- 2019-05-28
- Primary completion
- 2024-03-15
- Completion
- 2024-03-15
- First posted
- 2019-05-15
- Last updated
- 2024-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03951792. Inclusion in this directory is not an endorsement.